(Q36659502)

15 August 2017

1 reference

title

Inflammation and diabetic nephropathy (English)

1 reference

15 August 2017

Carmen Mora

1

1 reference

PubMed ID

17118230

15 August 2017

Juan F Navarro

series ordinal

2

1 reference

15 August 2017

1 December 2006

1 reference

15 August 2017

Current diabetes report

1 reference

15 August 2017

6

1 reference

15 August 2017

463-468

1 reference

15 August 2017

6

1 reference

https://scigraph.springernature.com/pub.10.1007/s11892-006-0080-1

15 August 2017

0 references

cites work

Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS).

1 reference

https://api.crossref.org/works/10.1007%2FS11892-006-0080-1

Pravastatin and the development of diabetes mellitus: evidence for a protective treatment effect in the West of Scotland Coronary Prevention Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-006-0080-1

Pharmacologic prevention or delay of type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-006-0080-1

Pentoxifylline ameliorates proteinuria through suppression of renal monocyte chemoattractant protein-1 in patients with proteinuric primary glomerular diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-006-0080-1

Circulating monocyte chemoattractant protein-1 and early development of nephropathy in type 1 diabetes

21 January 2018

1 reference

12 December 2020

Intercellular adhesion molecule-1 deficiency is protective against nephropathy in type 2 diabetic db/db mice

1 reference

12 December 2020

Interleukin-6 gene polymorphism and insulin sensitivity.

1 reference

12 December 2020

Pentoxifylline attenuated the renal disease progression in rats with remnant kidney.

1 reference

12 December 2020

Suppression of experimental systemic lupus erythematosus (SLE) in mice via TNF inhibition by an anti-TNFalpha monoclonal antibody and by pentoxiphylline

1 reference

12 December 2020

Plasma interleukin-6, tumour necrosis factor alpha and blood cytokine production in type 2 diabetes

1 reference

12 December 2020

Effects of pentoxifylline administration on urinary N-acetyl-beta-glucosaminidase excretion in type 2 diabetic patients: a short-term, prospective, randomized study

1 reference

12 December 2020

Pentoxifylline attenuates experimental mesangial proliferative glomerulonephritis

1 reference

12 December 2020

Leukocyte and endothelial cell adhesion molecules as targets for therapeutic interventions in inflammatory disease

1 reference

12 December 2020

Impaired glucose tolerance is associated with increased serum concentrations of interleukin 6 and co-regulated acute-phase proteins but not TNF-alpha or its receptors

1 reference

12 December 2020

Monocyte chemoattractant protein-1 promotes the development of diabetic renal injury in streptozotocin-treated mice

1 reference

12 December 2020

Tumor necrosis factor induces glomerular damage in the rabbit

1 reference

12 December 2020

Markers of inflammation and prediction of diabetes mellitus in adults (Atherosclerosis Risk in Communities study): a cohort study

1 reference

12 December 2020

Urinary and renal interstitial concentrations of TNF-alpha increase prior to the rise in albuminuria in diabetic rats

1 reference

12 December 2020

Clinical review 145: Pleiotropic effects of statins: lipid reduction and beyond

1 reference

12 December 2020

Cytokine regulation of ICAM-1 expression on human renal tubular epithelial cells in vitro

1 reference

12 December 2020

Interleukin 1 and tumor necrosis factor synergistically stimulate prostaglandin synthesis and phospholipase A2 release from rat renal mesangial cells

1 reference

12 December 2020

Plasma soluble intercellular adhesion molecule 1 levels are increased in type 2 diabetic patients with nephropathy

1 reference

12 December 2020

Dexamethasone and pentoxifylline inhibit endotoxin-induced cachectin/tumor necrosis factor synthesis at separate points in the signaling pathway

1 reference

12 December 2020

Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes: the insulin resistance atherosclerosis study

1 reference

12 December 2020

Expression of ICAM-1 on glomeruli is associated with progression of diabetic nephropathy in a genetically obese diabetic rat, Wistar fatty.

1 reference

12 December 2020

Pentoxifylline reduces proteinuria in insulin-dependent and non insulin-dependent diabetic patients

1 reference

12 December 2020

Targeting ICAM-1/LFA-1 interaction for controlling autoimmune diseases: designing peptide and small molecule inhibitors

1 reference

12 December 2020

Tumor necrosis factor in renal injury

1 reference

12 December 2020

Macrophages in mouse type 2 diabetic nephropathy: correlation with diabetic state and progressive renal injury

1 reference

12 December 2020

Pentoxifylline ameliorates renal tumor necrosis factor expression, sodium retention, and renal hypertrophy in diabetic rats

1 reference

12 December 2020

Monocyte chemoattractant protein-1.

1 reference

12 December 2020

Possible role of tumor necrosis factor and interleukin-1 in the development of diabetic nephropathy

1 reference

12 December 2020

Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of Ikkbeta

1 reference

12 December 2020

Prevention of early renal injury by mycophenolate mofetil and its mechanism in experimental diabetes

1 reference

12 December 2020

Methotrexate prevents renal injury in experimental diabetic rats via anti-inflammatory actions

1 reference

12 December 2020

Tumor necrosis factor stimulates prostaglandin production and cyclic AMP levels in rat cultured mesangial cells

1 reference

12 December 2020

Intercellular Adhesion Molecule-1–Deficient Mice Are Resistant Against Renal Injury After Induction of Diabetes

1 reference

12 December 2020

Urinary levels of monocyte chemoattractant protein-1 (MCP-1) and interleukin-8 (IL-8), and renal injuries in patients with type 2 diabetic nephropathy.

1 reference

12 December 2020

Tumor necrosis factor and interleukin 1 alpha increase vascular endothelial permeability

1 reference

12 December 2020

Urinary protein excretion and serum tumor necrosis factor in diabetic patients with advanced renal failure: effects of pentoxifylline administration

1 reference

12 December 2020

Serum interleukin-18 levels are associated with nephropathy and atherosclerosis in Japanese patients with type 2 diabetes

1 reference

12 December 2020

PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines

1 reference

12 December 2020

Spironolactone prevents early renal injury in streptozotocin-induced diabetic rats

1 reference

12 December 2020

Inflammatory cytokines and the risk to develop type 2 diabetes: results of the prospective population-based European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study

1 reference

12 December 2020

Combination of pentoxifylline with angiotensin converting enzyme inhibitors produces an additional reduction in microalbuminuria in hypertensive type 2 diabetic patients.

1 reference

12 December 2020

Association between circulating monocyte chemoattractant protein-1 and urinary albumin excretion in nonobese Type 2 diabetic patients

1 reference

12 December 2020

Mycophenolate mofetil prevents the development of glomerular injury in experimental diabetes

1 reference

12 December 2020

Association of monocyte chemoattractant protein-1 with renal tubular damage in diabetic nephropathy

1 reference

12 December 2020

Tumor necrosis factor-alpha gene expression in diabetic nephropathy: relationship with urinary albumin excretion and effect of angiotensin-converting enzyme inhibition.

1 reference

12 December 2020

Beneficial impact of spironolactone in diabetic nephropathy

1 reference

12 December 2020

Acute-phase markers of inflammation and glomerular structure in patients with type 2 diabetes

1 reference

12 December 2020

The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation

1 reference

12 December 2020

Early events leading to renal injury in obese Zucker (fatty) rats with type II diabetes

1 reference

12 December 2020

Pentoxifylline suppression of tumor necrosis factor gene transcription

1 reference

12 December 2020

Increased expression in adipocytes of ob RNA in mice with lesions of the hypothalamus and with mutations at the db locus

1 reference

12 December 2020

Tumour necrosis factor-alpha gene promoter polymorphism and decreased insulin resistance

1 reference

12 December 2020

C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus

1 reference

12 December 2020

Biological and clinical aspects of interleukin 6.

1 reference

12 December 2020

Pentoxifylline suppresses renal tumour necrosis factor-alpha and ameliorates experimental crescentic glomerulonephritis in rats

1 reference

12 December 2020

Is type II diabetes mellitus a disease of the innate immune system?

1 reference

12 December 2020

Body mass index, diabetes, and C-reactive protein among U.S. adults

1 reference

12 December 2020

Elevated levels of interleukin-18 and tumor necrosis factor-alpha in serum of patients with type 2 diabetes mellitus: relationship with diabetic nephropathy

1 reference

12 December 2020

Aldosterone blockade attenuates urinary monocyte chemoattractant protein-1 and oxidative stress in patients with type 2 diabetes complicated by diabetic nephropathy

1 reference

12 December 2020

Primary structure of ICAM-1 demonstrates interaction between members of the immunoglobulin and integrin supergene families

1 reference

12 December 2020

Erythromycin ameliorates renal injury via anti-inflammatory effects in experimental diabetic rats

1 reference

12 December 2020

Advanced glycation end products-cytokine-nitric oxide sequence pathway in the development of diabetic nephropathy: aminoguanidine ameliorates the overexpression of tumour necrosis factor-alpha and inducible nitric oxide synthase in diabetic rat glom

1 reference

12 December 2020

Spironolactone prevents diabetic nephropathy through an anti-inflammatory mechanism in type 2 diabetic rats

1 reference

12 December 2020

Urinary tumor necrosis factor contributes to sodium retention and renal hypertrophy during diabetes

1 reference

12 December 2020

TNF-alpha increases albumin permeability of isolated rat glomeruli through the generation of superoxide

1 reference

12 December 2020

Type 2 diabetes mellitus: a disease of the innate immune system? An update

1 reference

12 December 2020

End-stage renal failure in type 2 diabetes: A medical catastrophe of worldwide dimensions

1 reference

12 December 2020

Additive antiproteinuric effect of pentoxifylline in patients with type 2 diabetes under angiotensin II receptor blockade: a short-term, randomized, controlled trial

1 reference

12 December 2020

Inflammatory parameters are independently associated with urinary albumin in type 2 diabetes mellitus.

1 reference

12 December 2020

Plasma concentrations of VCAM-1 and ICAM-1 are elevated in patients with Type 1 diabetes mellitus with microalbuminuria and overt nephropathy

1 reference

12 December 2020

mRNA expression of growth factors in glomeruli from diabetic rats

1 reference

12 December 2020

Beneficial effects of adding spironolactone to recommended antihypertensive treatment in diabetic nephropathy: a randomized, double-masked, cross-over study

1 reference

12 December 2020

Subclinical inflammation in newly detected Type II diabetes and impaired glucose tolerance

1 reference

12 December 2020

10.1007/S11892-006-0080-1

Identifiers

DOI

1 reference

15 August 2017

1 reference

PubMed ID

17118230